Showing results (71-80 of 714) with videos related to
Sort By:
Pageof 72
The Annals of Thoracic Surgery|July 26, 2005
Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgeryChristopher P Cannon, Shamir R Mehta, Sary F ArankiJournal of General Internal Medicine|March 14, 2007
Gender differences in aspirin use among adults with coronary heart disease in the United StatesAlexander R Opotowsky, J Michael McWilliams, Christopher P CannonAmerican Heart Journal|October 31, 2007
New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?John P Morrow, Christopher P Cannon, James A ReiffelCurrent Atherosclerosis Reports|May 24, 2023
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?Mario Enrico Canonico, Connie N Hess, Christopher P CannonCurrent Atherosclerosis Reports|November 16, 2007
Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patientsChristopher T Dibble, Eli V Gelfand, Christopher P CannonCirculation. Cardiovascular Interventions|July 17, 2020
Novel Oral Anticoagulants Following Percutaneous Coronary InterventionBryan Q Abadie, Christopher P Cannon, Matthew A CavenderCritical Pathways in Cardiology|October 13, 2011
Results of a survey assessing provider beliefs of adherence barriers to antiplatelet medicationsGary C Bird, Christopher P Cannon, Richard H KennisonEuropean Heart Journal Open|September 19, 2022
Low levels of low-density lipoprotein cholesterol, intracerebral haemorrhage, and other safety issues: is there still a matter of debate?Pierre Sabouret, Denis Angoulvant, Christopher P Cannon, et al.Journal of Cardiovascular Development and Disease|May 26, 2023
Long-Term Sports Practice and Atrial Fibrillation: An Updated Review of a Complex RelationshipMattia Petrungaro, Liuba Fusco, Elena Cavarretta, et al.Critical Pathways in Cardiology|March 11, 2010
Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trialsSimona Mega, Giuseppe Patti, Christopher P Cannon, et al.Pageof 72